Interventional procedure overview of maximal effort cytoreductive surgery for advanced ovarian cancer
Closed for comments This consultation ended on at Request commenting lead permission
Additional information considered by IPAC
Professional experts' opinions
Expert advice was sought from consultants who have been nominated or ratified by their professional Society or Royal College. The advice received is their individual opinion and is not intended to represent the view of the society. The advice provided by professional experts, in the form of the completed questionnaires, is normally published in full on the NICE website during public consultation, except in circumstances but not limited to, when comments are considered voluminous, or publication would be unlawful or inappropriate.
10 professional expert questionnaires were submitted and can be found on the NICE website.
Patient organisation opinions
Patient organisation submissions were received and can be found on the NICE website.
Patient commentators' opinions
NICE received 14 questionnaires from patients who had the procedure (or their carers).
Patients' views on the procedure were consistent with the published evidence and the opinions of the professional experts. See the patient commentary summary for more information.
Company engagement
A structured information request was sent to 1 company who manufactures a potentially relevant device for use in this procedure. NICE received 1 completed submission. This was considered by the IP team and any relevant points have been taken into consideration when preparing this overview.
Issues for consideration by IPAC
Evidence on recurrent ovarian cancer has not been included.
Ongoing trials:
Trial on Radical Upfront Surgery in Advanced Ovarian Cancer (NCT02828618); Randomised controlled trial; US, Austria, Denmark, France, Germany, Italy, Sweden, UK; n=797; estimated completion date April 2023.
Laparoscopic cytoreduction After Neoadjuvant ChEmotherapy (LANCE); randomised controlled trial; US; n=580; estimated completion date May 2023.
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions